Perinatal Outcomes after Short versus Prolonged Indomethacin for Tocolysis in Women with Preterm Labor

Eryn H. Dutta, Faranak Behnia, Hassan Harirah, Maged Costantine, George Saade

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    Objective Indomethacin tocolysis is generally limited to 48 hours. Indomethacin has been administered for longer durations to prolong gestation in extreme prematurity. Our aim is to compare perinatal outcomes after a prolonged course, > 48 hours versus ≤ 48 hours in preterm labor. Methods A retrospective chart review of women admitted with preterm labor <32 weeks gestation who received indomethacin for tocolysis. The primary maternal outcome was latency from admission until delivery. The primary neonatal outcome was a composite of severe neonatal morbidities. Results A total of 73 women were included: 32 (43.8%) received indomethacin for > 48 hours (prolonged) and 41 (56.2%) for ≤ 48 hours (standard). Prolonged group started on indomethacin at an earlier gestational age compared with standard group (23.9 [23.1–27.3] vs. 25.7 [23.8–28.5] weeks, p = 0.03). Latency from admission until delivery was longer in the prolonged group versus the standard group (1.8 [1.1–3] vs. 0.4 [0.1–0.8] weeks, p <0.001). Prolonged use was not associated with increased risk of the composite neonatal outcome; however, there was a trend for more necrotizing enterocolitis. Conclusion A prolonged course of indomethacin may be an option for women with preterm labor at risk of extreme prematurity; it may also be associated with higher risks of some adverse neonatal outcomes.

    Original languageEnglish (US)
    JournalAmerican Journal of Perinatology
    DOIs
    StateAccepted/In press - Feb 1 2016

    Fingerprint

    Tocolysis
    Premature Obstetric Labor
    Indomethacin
    Necrotizing Enterocolitis
    Gestational Age
    Pregnancy

    Keywords

    • indomethacin
    • necrotizing enterocolitis
    • neonatal outcomes
    • preterm labor
    • tocolysis

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health
    • Obstetrics and Gynecology

    Cite this

    Perinatal Outcomes after Short versus Prolonged Indomethacin for Tocolysis in Women with Preterm Labor. / Dutta, Eryn H.; Behnia, Faranak; Harirah, Hassan; Costantine, Maged; Saade, George.

    In: American Journal of Perinatology, 01.02.2016.

    Research output: Contribution to journalArticle

    @article{004e5974675544aa9b267449f11b4924,
    title = "Perinatal Outcomes after Short versus Prolonged Indomethacin for Tocolysis in Women with Preterm Labor",
    abstract = "Objective Indomethacin tocolysis is generally limited to 48 hours. Indomethacin has been administered for longer durations to prolong gestation in extreme prematurity. Our aim is to compare perinatal outcomes after a prolonged course, > 48 hours versus ≤ 48 hours in preterm labor. Methods A retrospective chart review of women admitted with preterm labor <32 weeks gestation who received indomethacin for tocolysis. The primary maternal outcome was latency from admission until delivery. The primary neonatal outcome was a composite of severe neonatal morbidities. Results A total of 73 women were included: 32 (43.8{\%}) received indomethacin for > 48 hours (prolonged) and 41 (56.2{\%}) for ≤ 48 hours (standard). Prolonged group started on indomethacin at an earlier gestational age compared with standard group (23.9 [23.1–27.3] vs. 25.7 [23.8–28.5] weeks, p = 0.03). Latency from admission until delivery was longer in the prolonged group versus the standard group (1.8 [1.1–3] vs. 0.4 [0.1–0.8] weeks, p <0.001). Prolonged use was not associated with increased risk of the composite neonatal outcome; however, there was a trend for more necrotizing enterocolitis. Conclusion A prolonged course of indomethacin may be an option for women with preterm labor at risk of extreme prematurity; it may also be associated with higher risks of some adverse neonatal outcomes.",
    keywords = "indomethacin, necrotizing enterocolitis, neonatal outcomes, preterm labor, tocolysis",
    author = "Dutta, {Eryn H.} and Faranak Behnia and Hassan Harirah and Maged Costantine and George Saade",
    year = "2016",
    month = "2",
    day = "1",
    doi = "10.1055/s-0036-1579647",
    language = "English (US)",
    journal = "American Journal of Perinatology",
    issn = "0735-1631",
    publisher = "Thieme Medical Publishers",

    }

    TY - JOUR

    T1 - Perinatal Outcomes after Short versus Prolonged Indomethacin for Tocolysis in Women with Preterm Labor

    AU - Dutta, Eryn H.

    AU - Behnia, Faranak

    AU - Harirah, Hassan

    AU - Costantine, Maged

    AU - Saade, George

    PY - 2016/2/1

    Y1 - 2016/2/1

    N2 - Objective Indomethacin tocolysis is generally limited to 48 hours. Indomethacin has been administered for longer durations to prolong gestation in extreme prematurity. Our aim is to compare perinatal outcomes after a prolonged course, > 48 hours versus ≤ 48 hours in preterm labor. Methods A retrospective chart review of women admitted with preterm labor <32 weeks gestation who received indomethacin for tocolysis. The primary maternal outcome was latency from admission until delivery. The primary neonatal outcome was a composite of severe neonatal morbidities. Results A total of 73 women were included: 32 (43.8%) received indomethacin for > 48 hours (prolonged) and 41 (56.2%) for ≤ 48 hours (standard). Prolonged group started on indomethacin at an earlier gestational age compared with standard group (23.9 [23.1–27.3] vs. 25.7 [23.8–28.5] weeks, p = 0.03). Latency from admission until delivery was longer in the prolonged group versus the standard group (1.8 [1.1–3] vs. 0.4 [0.1–0.8] weeks, p <0.001). Prolonged use was not associated with increased risk of the composite neonatal outcome; however, there was a trend for more necrotizing enterocolitis. Conclusion A prolonged course of indomethacin may be an option for women with preterm labor at risk of extreme prematurity; it may also be associated with higher risks of some adverse neonatal outcomes.

    AB - Objective Indomethacin tocolysis is generally limited to 48 hours. Indomethacin has been administered for longer durations to prolong gestation in extreme prematurity. Our aim is to compare perinatal outcomes after a prolonged course, > 48 hours versus ≤ 48 hours in preterm labor. Methods A retrospective chart review of women admitted with preterm labor <32 weeks gestation who received indomethacin for tocolysis. The primary maternal outcome was latency from admission until delivery. The primary neonatal outcome was a composite of severe neonatal morbidities. Results A total of 73 women were included: 32 (43.8%) received indomethacin for > 48 hours (prolonged) and 41 (56.2%) for ≤ 48 hours (standard). Prolonged group started on indomethacin at an earlier gestational age compared with standard group (23.9 [23.1–27.3] vs. 25.7 [23.8–28.5] weeks, p = 0.03). Latency from admission until delivery was longer in the prolonged group versus the standard group (1.8 [1.1–3] vs. 0.4 [0.1–0.8] weeks, p <0.001). Prolonged use was not associated with increased risk of the composite neonatal outcome; however, there was a trend for more necrotizing enterocolitis. Conclusion A prolonged course of indomethacin may be an option for women with preterm labor at risk of extreme prematurity; it may also be associated with higher risks of some adverse neonatal outcomes.

    KW - indomethacin

    KW - necrotizing enterocolitis

    KW - neonatal outcomes

    KW - preterm labor

    KW - tocolysis

    UR - http://www.scopus.com/inward/record.url?scp=84960354360&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84960354360&partnerID=8YFLogxK

    U2 - 10.1055/s-0036-1579647

    DO - 10.1055/s-0036-1579647

    M3 - Article

    JO - American Journal of Perinatology

    JF - American Journal of Perinatology

    SN - 0735-1631

    ER -